10 Sep 2025
// BIOSPACE
https://www.biospace.com/drug-development/cullinan-taihos-nsclc-hopeful-shows-strong-activity-clearing-road-to-fda
09 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302549926.html
25 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-announces-acceptance-of-abstract-for-zipalertinib-at-the-esmo-congress-2025-302513640.html
22 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-acceptance-of-abstracts-for-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302510269.html
01 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-pivotal-rezilient1-phase-12-data-published-in-the-journal-of-clinical-oncology-302470143.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3087169/0/en/Cullinan-Therapeutics-Taiho-Pharmaceutical-and-Taiho-Oncology-to-Present-Positive-Results-from-Pivotal-Phase-2b-REZILIENT1-Trial-of-Zipalertinib-at-ASCO-2025.html